Assessing and Treating Pediatric Patients With Mood Disorders
Assignment: Assessing and Treating Pediatric Patients With Mood Disorders
When pediatric patients present with mood disorders, the process of assessing, diagnosing, and treating them can be quite complex. Children not only present with different signs and symptoms than adult patients with the same disorders, they also metabolize medications much differently. Yet, there may be times when the same psychopharmacologic treatments may be used in both pediatric and adult cases with major depressive disorders. As a result, psychiatric nurse practitioners must exercise caution when prescribing psychotropic medications to these patients. For this Assignment, as you examine the patient case study in this week’s Learning Resources, consider how you might assess and treat pediatric patients presenting with mood disorders.
To prepare for this Assignment:
Review this week’s Learning Resources, including the Medication Resources indicated for this week.
Reflect on the psychopharmacologic treatments you might recommend for the assessment and treatment of pediatric patients requiring antidepressant therapy.
The Assignment: 5 pages
Examine Case Study: An African American Child Suffering From Depression. You will be asked to make three decisions concerning the medication to prescribe to this patient. Be sure to consider factors that might impact the patient’s pharmacokinetic and pharmacodynamic processes.
At each decision point, you should evaluate all options before selecting your decision and moving throughout the exercise. Before you make your decision, make sure that you have researched each option and that you evaluate the decision that you will select. Be sure to research each option using the primary literature.
Introduction to the case (1 page)
Briefly explain and summarize the case for this Assignment. Be sure to include the specific patient factors that may impact your decision making when prescribing medication for this patient.
Decision #1 (1 page)
Which decision did you select?
Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.
Decision #2 (1 page)
Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.
Decision #3 (1 page)
Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.
Conclusion (1 page)
Summarize your recommendations on the treatment options you selected for this patient. Be sure to justify your recommendations and support your response with clinically relevant and patient-specific resources, including the primary literature. CORE SKILL: pediatric psychopharmacology is not adult psychopharmacology with smaller numbers. Development changes the diagnosis, the pharmacokinetics, and the ethics.
DIAGNOSTIC DIFFERENCES IN CHILDREN: depressed mood may present as IRRITABILITY rather than sadness (DSM-5-TR explicitly allows irritable mood as the Criterion A qualifier in children and adolescents); somatic complaints, school refusal, and social withdrawal are common presentations. Mania in children is harder — and the field’s response to overdiagnosis of pediatric bipolar disorder was the creation of DISRUPTIVE MOOD DYSREGULATION DISORDER (DMDD): severe recurrent temper outbursts plus persistently irritable/angry mood BETWEEN outbursts, onset before age 10, diagnosed between 6 and 18. Knowing WHY DMDD was added — to curb the diagnostic inflation of pediatric bipolar and the antipsychotic prescribing that followed — is exactly the kind of context that earns high marks.
PHARMACOKINETIC DIFFERENCES: children have proportionally larger livers relative to body mass and often METABOLIZE DRUGS FASTER, sometimes requiring higher weight-adjusted doses or divided dosing; body composition (water and fat fractions) shifts volume of distribution; renal clearance matures over the first years.
THE BOXED WARNING you must address: all antidepressants carry an FDA boxed warning for INCREASED SUICIDAL IDEATION AND BEHAVIOR in children, adolescents, and young adults up to 25. Handle it with nuance rather than alarm — the finding was increased ideation/behavior, with NO completed suicides in the trials; population-level data after the warning showed reduced prescribing accompanied by a rise in suicide attempts, suggesting untreated depression carries its own lethal risk. The clinical implication is not “don’t prescribe” but “monitor closely,” especially in the first weeks and after dose changes, with a documented safety plan.
EVIDENCE BASE: FLUOXETINE is FDA-approved for pediatric depression from age 8 and has the strongest evidence; escitalopram is approved from age 12. The TADS trial found the combination of fluoxetine + CBT superior to either alone. PSYCHOTHERAPY IS FIRST-LINE for mild-to-moderate presentations — a decision tree that goes straight to medication without addressing therapy will be marked down.
FOR THE DECISION TREE ASSIGNMENT: at each node, state the decision, the RATIONALE grounded in evidence, what you EXPECTED to happen, what ACTUALLY happened, and why any difference occurred. The rubric wants explicit ethical consideration at each point — and in pediatrics that means ASSENT from the child alongside PARENTAL CONSENT, off-label prescribing disclosure, family involvement, school coordination, and cultural factors in how the family understands mental illness.
MONITORING: growth and weight, metabolic parameters if an antipsychotic is used, activation/behavioral disinhibition (more common in children than adults), and emergence of manic symptoms.
Collepals.com Plagiarism Free Papers
Are you looking for custom essay writing service or even dissertation writing services? Just request for our write my paper service, and we'll match you with the best essay writer in your subject! With an exceptional team of professional academic experts in a wide range of subjects, we can guarantee you an unrivaled quality of custom-written papers.
Get ZERO PLAGIARISM, HUMAN WRITTEN ESSAYS
Why Hire Collepals.com writers to do your paper?
Quality- We are experienced and have access to ample research materials.
We write plagiarism Free Content
Confidential- We never share or sell your personal information to third parties.
Support-Chat with us today! We are always waiting to answer all your questions.
